The design of our study was cross-sectional i.e., one point in time, so for better observation and proper understanding of the patterns of bone marrow infiltration in NHL patients with β2m and LD2 levels, cohort study should be designed and followed. The gene discussed is B2M; the disease is non-Hodgkin lymphoma.